NASDAQ:BPTH

Bio-path Holdings Stock Predictions

etoro logo Buy BPTH
*Your capital is at risk
$0.0300
+0.0066 (+28.21%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BPTH Prediction Chart

BPTH Predictions History

Latest community submissions for BPTH.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Mar 15, 2019 $25.22 -95.71% $29.40 V 85.80% 0
Mar 14, 2019 $32.58 -94.07% $27.47 X 81.40% 0
JS JS Pro
Mar 14, 2019 $27.62 -94.97% $27.47 V 99.50% 3
Sergiu Sergiu @Sergiu.103823
Mar 14, 2019 $25.09 -95.43% $27.47 V 91.30% 0
JS JS Pro
Mar 12, 2019 $31.22 -95.56% $35.13 V 88.90% 0
Sergiu Sergiu @Sergiu.103823
Mar 12, 2019 $35.12 -95.00% $35.13 X 100.00% 10
Mar 7, 2019 $10.91 -98.60% $38.86 V 28.10% 0
JS JS Pro
Mar 7, 2019 $11.37 -98.54% $38.86 V 29.30% 0
Gp Gp Merchant @Gp.98898
Mar 7, 2019 $10.84 -98.61% $38.86 V 27.90% 0
Feb 8, 2019 $2.13 -94.73% $2.02 X 94.60% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BPTH with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIO-PATH HOLDINGS
Bio-Path Holdings
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE